Cyclacel Announces Presentation of Results From Phase 3 Seamless Study at Ash Annual Meeting
December 12, 2017 07:00 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) "Cyclacel" or the "Company"), a biopharmaceutical company developing oral...